US$ 27.42
bpc-157 and thymosin beta-4 combination study / TB-500 Blend (Dual Peptide) BPC-157 vs TB-500: Recovery Peptide
Description
Piotto S

At the end of the study, it was suggested that CJC-1295 contributed to a 7.5-fold increase in the growth hormone pulsatility levels as compared to that of the placebo

Because BPC-157 is not FDA approved for general medical use and human safety data remains limited, patients should not self-dose, order research peptides online, or use BPC-157 without medical supervision

Further research is necessary to fully validate their therapeutic potentials
Disclaimer: This product is sold strictly for laboratory research purposes
